Short answer. A stability report tells you how a material’s measured attributes changed over time under a stated storage condition — nothing more and nothing less. It is only as trustworthy as four things it names: the storage condition with its tolerance, the container the material actually sat in, the analytical method and whether it is stability-indicating, and the acceptance criteria the results were judged against. If any one of those four is missing, the shelf life printed on the cover page is a number without a basis. This page is a reading guide for buyers, not a statement about any particular product.
What a stability report is, and what it is not
Most stability reports circulating in the US supplement supply chain are written in the vocabulary of ICH Q1A(R2), Stability Testing of New Drug Substances and Products (Step 4 version dated 6 February 2003). That guideline defines the stability data package for a new drug substance or drug product for registration in the EC, Japan and the United States. It is a pharmaceutical registration guideline. It does not govern dietary supplements, and reading it as though it did is the most common mistake made at both ends of a quote.
Two consequences follow, and they point in opposite directions. First, an ingredient supplier who runs a properly designed ICH-style study on a dietary ingredient is doing something entirely voluntary, and a real study is a genuine differentiator. Second, the words “ICH compliant” on a cover page are not something you can verify — the study design, the conditions, the container and the methods inside are. Read the inside.
The storage conditions a report should name
ICH Q1A(R2) sets out the storage conditions below. A report that does not state its condition together with a tolerance has not really stated a condition. Use this table to check what you were sent against what the guideline actually specifies.
| Study | Storage condition (ICH Q1A(R2)) | Minimum period covered by data at submission |
|---|---|---|
| Long term, general case | 25 °C ± 2 °C / 60% RH ± 5% RH, or 30 °C ± 2 °C / 65% RH ± 5% RH | 12 months |
| Intermediate, general case | 30 °C ± 2 °C / 65% RH ± 5% RH | 6 months |
| Accelerated, general case | 40 °C ± 2 °C / 75% RH ± 5% RH | 6 months |
| Long term, refrigerated | 5 °C ± 3 °C | 12 months |
| Accelerated, refrigerated | 25 °C ± 2 °C / 60% RH ± 5% RH | 6 months |
| Long term, frozen | −20 °C ± 5 °C | 12 months |
| Long term, semi-permeable container | 25 °C ± 2 °C / 40% RH ± 5% RH, or 30 °C ± 2 °C / 35% RH ± 5% RH | 12 months |
| Accelerated, semi-permeable container | 40 °C ± 2 °C / not more than 25% RH | 6 months |
Two reading notes on that table. Where 30 °C / 65% RH is chosen as the long-term condition, ICH Q1A(R2) provides no intermediate condition — so a report showing long term at 30 °C and no intermediate arm is not missing an arm. And the choice between the two long-term options belongs to whoever designed the study, so ask which was used and why, rather than assuming 25 °C.
Seven checks before you accept a shelf life
1. “Room temperature” is not a storage condition
ICH Q1A(R2) is explicit in its labelling sections for both drug substances and drug products: terms such as “ambient conditions” or “room temperature” should be avoided. If the storage-condition column of a report reads “room temperature” or “RT”, you have been told nothing you can reproduce, compare or write into a specification. Ask for the numeric condition and its tolerance. The phrase is also a moving target in its own right — the compendial definition of controlled room temperature has itself been the subject of revision proposals, which is exactly why a number beats a phrase.
2. Accelerated data does not settle physical stability
The ICH Q1A(R2) glossary says it plainly: results from accelerated testing studies are not always predictive of physical changes. A clean six-month run at 40 °C / 75% RH tells you something useful about chemical degradation rate. It does not tell you whether the material cakes, discolours, picks up moisture, loses flow or separates in your matrix. For a drug product the guideline’s own list of significant changes includes failure to meet acceptance criteria for appearance, physical attributes and functionality alongside the assay criterion — a physical failure is a failure, not a cosmetic footnote.
3. Know which “significant change” definition is being applied
These are two different definitions in the same guideline and they are routinely conflated. For a drug substance, ICH Q1A(R2) defines significant change simply as failure to meet its specification. For a drug product, it is defined as a 5% change in assay from the initial value, or failure to meet the acceptance criteria for potency by biological or immunological procedures; any degradation product exceeding its acceptance criterion; failure on appearance, physical attributes or functionality; and, as appropriate to the dosage form, failure on pH or on dissolution for 12 dosage units. A raw material is the substance case. So “assay only dropped 4%, still within spec” is an answer to the product question, not the substance one. Ask which definition the report used and against which written specification.
4. Check mass balance before you read the assay column
ICH Q1A(R2) defines mass balance as adding together the assay value and the levels of degradation products to see how closely these add up to 100% of the initial value, with due consideration of the margin of analytical error. This is the fastest integrity check available to a reviewer. If assay falls over time and no degradation product rises to meet it, then either the method is not detecting what is forming, or the loss is not chemical, or the numbers are not from the same samples. The guideline requires validated, stability-indicating analytical procedures for exactly this reason. Ask for the method, its validation status, and the degradant profile — not only the assay row.
5. The container is part of the result
ICH Q1A(R2) requires the study to be conducted in a container closure system that is the same as, or simulates, the packaging proposed for storage and distribution. A number generated on powder in a sealed foil-lined drum does not transfer to a pectin gummy, a stick-pack film or a clear PET bottle. Ask what was actually in the chamber. If the packaging is semi-permeable, ask about water loss specifically: the guideline treats a 5% loss of water from the initial value as a significant change after the equivalent of three months at 40 °C / not more than 25% RH.
6. Count the batches, the timepoints and the excursions
ICH Q1A(R2) expects data from at least three primary batches. It expects long-term testing normally every three months over the first year, every six months over the second year, and annually thereafter; and at the accelerated condition a minimum of three timepoints including the initial and final ones, for example 0, 3 and 6 months. It also expects honesty about the chamber: excursions that exceed the defined storage tolerances for more than 24 hours should be described in the study report and their effect assessed. A single-batch, two-timepoint report with no excursion statement is a data point, not a stability study — which does not make it useless, but does mean you should describe it that way internally.
7. Ask how much of the shelf life is real time and how much is projection
ICH Q1A(R2) permits limited extrapolation of real-time long-term data beyond the observed range when it is justified, and it is candid that such extrapolation assumes the same degradation relationship continues to apply outside the observed data. That assumption may be reasonable. It is still an assumption. So the question to put to a supplier is not “what is the shelf life” but “how many months of real-time data exist today, at which condition, and what does the rest of the number rest on”. The answer is usually given willingly, and how it is given tells you a good deal about the supplier.
Where the US dietary supplement rules actually sit
US dietary supplement manufacturing sits under 21 CFR part 111, the cGMP regulation for manufacturing, packaging, labeling or holding operations for dietary supplements. Part 111 does not require a shelf life or expiration date on a dietary supplement at all. The clearest evidence of that is in the regulation’s own conditional language: 21 CFR 111.83(a)(3) requires a reserve sample to be retained “for 1 year past the shelf life date (if shelf life dating is used), or for 2 years from the date of distribution of the last batch of dietary supplements associated with the reserve sample”. The parenthesis is the tell. The American Herbal Products Association reaches the same reading in its 2011 guidance on shelf life dating, noting that FDA does not require the dating, that the regulations use the phrase “if shelf life dating is used”, and that where dating is used it should be supported by data.
What that means practically for a sourcing or quality reviewer: a raw-material stability report is a voluntary demonstration by the supplier, not a compliance artefact you can point an auditor at. It is still one of the most informative documents in the pack, because it is the one place where a supplier shows its method, its acceptance criteria and its willingness to publish an unflattering timepoint. Determination of dating and label statements for your own finished product belongs with your quality and regulatory reviewers.
What to request, in one list
- The full study protocol, not only the summary table: condition and tolerance, container closure system, batch identities, timepoints and test list.
- The analytical method for each attribute, its validation status, and confirmation that it is stability-indicating.
- The written specification and acceptance criteria the results were judged against, with the release and shelf-life criteria distinguished if they differ.
- The degradation product data alongside the assay data, so mass balance can be checked.
- A statement of any chamber excursions exceeding the storage tolerances for more than 24 hours, and their assessed effect.
- How many months of real-time long-term data exist as of today, and what any longer figure is extrapolated from.
- Photostability information where the material or the pack makes light exposure plausible, per ICH Q1B.
- Where you are formulating a gummy, stick pack, beverage or chewable, a clear statement of whether matrix-specific data exists or does not.
Where we hold stability information for a material, we supply it with the storage condition, container, method and acceptance criteria stated. Where we do not hold it for a given matrix, we say so rather than hand over a number with no basis behind it. Documentation is provided under buyer review.
What we do not claim on this page
- This is a guide to reading a report. It is not a statement about the stability of any particular material, and no figure quoted here is a specification for any Nutrition BioTech product.
- We do not claim that ICH Q1A(R2) applies to dietary supplements, and we do not describe our materials as ICH-compliant, FDA-approved or clinically proven.
- Nothing here is a health, disease, treatment or performance claim about any ingredient.
- Nothing here is regulatory advice. Shelf-life determination, dating and label statements for your finished product are decisions for your own quality and regulatory reviewers.
References
- ICH Harmonised Tripartite Guideline Q1A(R2), Stability Testing of New Drug Substances and Products, Step 4 version dated 6 February 2003 — ich.org.
- ICH Harmonised Tripartite Guideline Q1B, Photostability Testing of New Drug Substances and Products.
- 21 CFR 111.83, requirements for reserve samples, within 21 CFR part 111 — eCFR.
- American Herbal Products Association, Shelf Life Dating of Botanical Supplement Ingredients and Products (AHPA: Silver Spring, MD, 2011).
Related guides
- How to verify a supplier COA — the document a stability report should be read next to.
- How to qualify a nutraceutical ingredient supplier — where stability sits in a wider due-diligence pass.
- Quality and certifications — what we hold and what is available on request.
- Ingredient selection guides — comparisons and buyer-process guides in one place.
- L-5-MTHF vs folic acid and live vs pasteurized Akkermansia — two comparisons where matrix stability decides the answer.
- Ingredient catalog.
Frequently asked questions
Does a dietary supplement ingredient have to have a stability report?
No. US dietary supplement cGMP under 21 CFR part 111 does not require shelf life or expiration dating, which is why the regulation uses the conditional phrase “if shelf life dating is used” in 21 CFR 111.83(a)(3). A supplier stability report is therefore voluntary. Where dating is used, the expectation is that it be supported by data, so most serious buyers ask for the study whether or not a regulation compels it.
Is six months of accelerated data enough to support a 24-month shelf life?
Not on its own. ICH Q1A(R2) treats accelerated data as a way to assess short-term excursions and to support limited, justified extrapolation of real-time long-term data — and it states that the extrapolation assumes the same degradation relationship continues to apply beyond the observed range. Ask how many months of real-time data exist at the long-term condition today, and treat the remainder as a projection that should be labelled as one.
What does “significant change” mean in a stability report?
It depends on what is being tested. ICH Q1A(R2) defines significant change for a drug substance as failure to meet its specification. For a drug product it defines significant change as a 5% change in assay from the initial value or failure of a biological or immunological potency criterion; any degradation product exceeding its acceptance criterion; failure on appearance, physical attributes or functionality; and, as appropriate, failure on pH or on dissolution for 12 dosage units. Ask which definition and which written specification the report is using.
Why does the packaging used in the study matter so much?
Because ICH Q1A(R2) requires the study to run in a container closure system that is the same as, or simulates, the packaging proposed for storage and distribution — the container is one of the variables under test, not background. Data generated on material in a sealed foil-lined drum does not transfer to a gummy, a stick pack or a clear bottle. For semi-permeable packaging, ask about water loss specifically; the guideline treats a 5% water loss from the initial value as a significant change after the equivalent of three months at 40 °C and not more than 25% RH.
What is a stability-indicating method, and why should we ask about it?
It is an analytical procedure validated to separate and measure the material of interest in the presence of the degradation products that actually form, so that a falling assay is detected rather than masked. ICH Q1A(R2) calls for validated stability-indicating analytical procedures in stability studies. The practical test for a reviewer is mass balance: assay plus measured degradation products should account for close to 100% of the initial value once analytical error is allowed for. If they do not, ask about the method before you argue about the result.
Can we use a supplier’s raw material stability data to set our finished product shelf life?
No. A raw material study run in supplier packaging under a stated condition tells you about that material in that container. Your finished product has a different matrix, different water activity, different excipients, a different pack and a different headspace, and its dating is your determination to make with your own quality and regulatory reviewers. Supplier data is an input to your study design and a reason to expect certain behaviour — it is not a substitute for a study on your own product.
Request a sample, COA or stability documentation
Tell us the material, the target format and the condition you need to hold it at, and we will send what we have with the protocol details stated. Contact Nutrition BioTech for samples, COAs, specifications and documentation.
Nutrition BioTech
1601 W. Mission Blvd, Suite 103 (DL#29), Pomona, CA 91766
(909) 745-1357 · [email protected]